Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Major Milestone For Diurnal As FDA Approves Alkindi
Partner Eton Predicts $100m Sales For Adrenal Insufficiency Drug
Sep 30 2020
•
By
Kevin Grogan
Diurnal celebrating after US approval of Alkindi • Source: Shutterstock
More from New Products
More from Scrip